6th International Conference on Cancer Research and Treatment

Cardio-oncology has emerged as a vital field addressing the interplay between cardiovascular health and cancer treatment. This session delves into the complexities of managing cardiovascular risks in cancer patients, offering cutting-edge insights into prevention, early detection, and intervention strategies. Participants will explore how oncology therapies, such as chemotherapy, immunotherapy, and targeted treatments, can impact heart health and learn about innovative approaches to minimize these effects without compromising cancer outcomes.

Cardiotoxicity from Chemotherapy:

Explore the cardiovascular impacts of chemotherapy, focusing on identifying, preventing, and managing cardiotoxic effects caused by treatments like anthracyclines and HER2-targeted therapies. Join expert discussions on strategies to safeguard heart health while optimizing cancer care outcomes.

Radiation-Induced Heart Disease (RIHD):

Examine the cardiovascular effects of thoracic radiation in cancer treatment. This session explores the mechanisms, prevention, and management of Radiation-Induced Heart Disease (RIHD), ensuring holistic care for patients undergoing therapy for thoracic cancers. Join expert discussions for deeper insights.

Arrhythmias:

This session explores the prevalence and management of arrhythmias in cancer patients, focusing on the cardiac effects of oncological therapies. Experts will discuss detection, prevention, and tailored treatments to mitigate risks and enhance patient outcomes in cardio-oncology care.

Thromboembolism and Hypercoagulability:

Delve into the crucial link between cancer and thrombosis, focusing on the mechanisms, risks, and management of hypercoagulable states in cancer patients. Discover innovative approaches to prevent thromboembolic complications and enhance patient outcomes in oncology care.

Hypertension in Cancer Care:

Explore the complexities of managing hypertension in cancer patients, a common side effect of targeted therapies. This session delves into effective strategies, risk assessments, and collaborative approaches to ensure optimal cardiovascular and oncological outcomes.

Coronary Artery Disease (CAD) in Cancer Patients:

This session will explore the intersection of cancer therapies and coronary artery disease, examining how treatments may accelerate atherosclerosis and increase the risk of ischemic heart disease, and highlighting strategies for early detection and management in cancer patients.